(1)shall not be designed to promote or encourage, directly, intravenous drug abuse or sexual activity, homosexual or heterosexual;
(2)shall be designed to reduce exposure to and transmission of HIV/AIDS by providing accurate information;
(3)shall provide information on the health risks of promiscuous sexual activity and intravenous drug abuse; and
(4)shall provide information on the transmission and prevention of hepatitis A, B, and C, including education about the availability of hepatitis A and B vaccines and assisting patients in identifying vaccination sites.
2009—Pub. L. 111–87repealed Pub. L. 109–415, § 703, and revived the provisions of this section as in effect on Sept. 30, 2009. See 2006 Amendment note and Effective Date of 2009 Amendment; Revival of Section note below.
2006—Pub. L. 109–415, § 703, which directed repeal of this section effective Oct. 1, 2009, was itself repealed by Pub. L. 111–87, § 2(a)(1), effective Sept. 30, 2009.
Par. (2). Pub. L. 109–415, § 702(3), substituted “HIV/AIDS” for “HIV disease”.
Effective Date of 2009 Amendment; Revival of Section
For provisions that repeal by section 2(a)(1) ofPub. L. 111–87of section 703 ofPub. L. 109–415be effective Sept. 30, 2009, and that the provisions of this section as in effect on Sept. 30, 2009, be revived, see section 2(a)(2), (3)(A) ofPub. L. 111–87, set out as a note under section
300ff–11 of this title.
The table below lists the classification updates, since Jan. 3, 2012, for this section. Updates to a broader range of sections may be found at the update page for containing chapter, title, etc.
The most recent Classification Table update that we have noticed was Monday, July 29, 2013
An empty table indicates that we see no relevant changes listed in the classification tables. If you suspect that our system may be missing something, please double-check with the Office of the Law Revision Counsel.
Description of Change
Statutes at Large
LII has no control over and does not endorse any external Internet site that contains links to or references LII.